Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc.

AGIO ·

Agios Pharmaceuticals, Inc. (AGIO) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Agios Pharmaceuticals, Inc. in 2026. The next earnings report is expected on October 29, 2026.

Earnings calendar

Next earnings date

29 Oct 2026

In 69 days

EPS estimate

-1.48

Revenue estimate

33.2M

Past earnings

30 Jul 2026
EPS actual
-1.69 (-2.1%)
estimate -1.65
Revenue actual
44.7M (+69.5%)
estimate 26.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
29 Apr 2026
EPS actual
-1.69 (+6.3%)
estimate -1.80
Revenue actual
20.7M (+56.0%)
estimate 13.3M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Feb 2026
EPS actual
-1.86 (+4.8%)
estimate -1.95
Revenue actual
20.0M (+65.1%)
estimate 12.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Agios Pharmaceuticals missed consensus estimates in its latest earnings report, with EPS of -$1.69 versus an expected -$1.6548 and revenue of $44.75 million exceeding estimates by 69.5%. In the prior report both EPS and revenue were ahead of expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Agios Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the discovery and development of treatments within cellular metabolism and associated biological domains. Its lead product, PYRUKYND (mitapivat), serves as an activator for both healthy and various mutated forms of the pyruvate kinase (PK) enzyme, targeting the management of hemolytic anemias. Additionally, AG-946, an investigational compound, is currently undergoing Phase I clinical evaluation for hemolytic anemias and other conditions. Established in 2007, Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Brian Goff
Employees
486
IPO date
29 Jan 2018
ISIN
US00847X1046
Website
agios.com

Frequently asked questions

When does Agios Pharmaceuticals, Inc. (AGIO) next report earnings?

Agios Pharmaceuticals, Inc. (AGIO) is scheduled to report earnings on October 29, 2026.

What was Agios Pharmaceuticals, Inc.'s most recent earnings date?

Agios Pharmaceuticals, Inc. (AGIO) last reported earnings on July 30, 2026.

Where is Agios Pharmaceuticals, Inc. stock listed?

Agios Pharmaceuticals, Inc. (AGIO) is listed on Nasdaq.